How Competitor Intelligence Teams Are Staying Ahead of Rival Moves Faster

Pharmaceutical and life sciences organisations face a distinct intelligence challenge in 2026. Patent expirations, regulatory shifts, M&A activity and biosimilar threats now move at a pace that makes manual monitoring impractical. AI has changed what’s possible in competitor intelligence work, but most teams are still deciding how to apply these tools to their specific monitoring requirements.

This 30-minute webinar will explore how leading life sciences and pharma intelligence teams are approaching AI for competitor monitoring. You’ll hear about the ways organisations are testing AI capabilities for clinical trial tracking, patent analysis, regulatory submissions and strategic developments, and the questions they’re asking about reliability, implementation and team adoption.

We’ll discuss the changes intelligence teams are considering for their workflows, the areas where AI shows the most promise for pharma monitoring, and what’s realistic to expect from these tools in the year ahead.

What we’ll cover:

• The potential for AI to support competitor intelligence across clinical trials, patent analysis, regulatory monitoring and M&A tracking in pharma
• What determines whether AI tools are suitable for pharmaceutical intelligence work and what to look for when evaluating them
• How teams are thinking about integrating AI into existing competitor monitoring processes and where the friction points appear
• Early examples of AI helping to surface signals in biosimilar activity, launch strategies and competitor positioning
• The questions intelligence leaders are asking about AI maturity, implementation and the future of pharma CI work

What you’ll take away

• A clearer understanding of where pharmaceutical intelligence functions stand with AI adoption in 2026
• Considerations for teams exploring AI support for competitor monitoring without compromising quality
• Perspective on the speed and coverage improvements AI might offer in pharma intelligence environments
• Insight into what’s changing in how organisations approach competitor intelligence in life sciences

Who should attend

This session is designed for intelligence and strategy professionals at pharmaceutical and life sciences organisations, including:

• Heads of Competitive Intelligence and Market Intelligence
• Competitor Intelligence Analysts and Managers
• Strategy and Research Directors in pharma and biotech
• Senior Intelligence Professionals tracking regulatory and patent developments
• Business Development and Innovation leaders requiring competitor insight
• Chief Knowledge Officers and Insights Directors in life sciences

Register now to secure your spot

Can’t attend live? Sign up anyway – we’ll send you the recording.